Ayat B. Al-Ghafari
Long-term exposure to irinotecan reduces cell migration in glioma cells.
Al-Ghafari, Ayat B.; Punjaruk, Wiyada; Storer, L.C.D.; Carrier, D.J.; Hussein, D.; Coyle, Beth; Kerr, Ian D.
Authors
Wiyada Punjaruk
L.C.D. Storer
D.J. Carrier
D. Hussein
Professor BETH COYLE BETH.COYLE@NOTTINGHAM.AC.UK
PROFESSOR OF BRAIN TUMOUR MICROENVIRONMENT
Ian D. Kerr
Abstract
In spite of considerable research into the therapies for glioblastoma multiforme this tumour type remains very difficult to treat. As well as having a tendency to be inherently resistant to chemotherapy, glioblastoma multiforme also displays local invasion. Cell line studies have a continued and important role to play in understanding the mechanisms associated with both chemotherapy resistance and invasion. In the current study we have utilized the C6 glioma cell line to investigate the response to long-term, clinically relevant application of topoisomerase I and II inhibitors. Treatment with etoposide resulted in an increase in resistance to this topoisomerase II inhibitor. By contrast, the continuous exposure to a topoisomerase I inhibitor did not result in increased drug resistance, but was associated with a reduction in cell migration. This data supports further investigation of topoisomerase I inhibition as a means to inhibit glioma invasion without the development of parallel chemoresistance.
Citation
Al-Ghafari, A. B., Punjaruk, W., Storer, L., Carrier, D., Hussein, D., Coyle, B., & Kerr, I. D. (2016). Long-term exposure to irinotecan reduces cell migration in glioma cells. Journal of Neuro-Oncology, 127(3), 455-462. https://doi.org/10.1007/s11060-016-2058-4
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 25, 2016 |
Online Publication Date | Jan 30, 2016 |
Publication Date | May 1, 2016 |
Deposit Date | Jun 21, 2016 |
Publicly Available Date | Jun 21, 2016 |
Journal | Journal of Neuro-Oncology |
Print ISSN | 0167-594X |
Electronic ISSN | 1573-7373 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 127 |
Issue | 3 |
Pages | 455-462 |
DOI | https://doi.org/10.1007/s11060-016-2058-4 |
Keywords | Glioma, Topoisomerase, Etoposide, Irinotecan, ABCB1, Invasion, Chemotherapy |
Public URL | https://nottingham-repository.worktribe.com/output/781914 |
Publisher URL | http://link.springer.com/article/10.1007%2Fs11060-016-2058-4 |
Additional Information | The final publication is available at Springer via http://dx.doi.org/10.1007/s11060-016-2058-4 |
Contract Date | Jun 21, 2016 |
Files
Al-Ghafari-final draft post-refereeing.pdf
(666 Kb)
PDF
You might also like
A time-resolved Förster resonance energy transfer assay to investigate inhibitor binding to ABCG2
(2023)
Preprint / Working Paper
Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search